CD8A and neoplasm: Conversely, PD-1-/- OT-1 CD8+ T-cells showed an augmented capacity to enhance Tc17 differentiation and mount immunity to tumor progression while producing IFN-γ upon adoptive transfer into tumor bearing mice.